《中国甲状腺功能亢进和其他原因甲状腺毒症诊治指南》要点解读  

Interprelation of key points in the Chinese Guidelines for the Diagnosis and'Treatment of Hyperthyroidism and Thyrotoxicosis of 0ther Causes

作　　者：崔永琪 李静[2] CUI Yong-qi;LI Jing(Liaoning University of Traditional Chinese Medicine,Shernyang 110847,China;不详)

机构地区：[1]辽宁中医药大学,辽宁沈阳110847 [2]中国医科大学附属第一医院内分泌与代谢病科,中国医科大学内分泌研究所,辽宁沈阳110001

出　　处：《中国实用内科杂志》2023年第11期881-883,889,共4页Chinese Journal of Practical Internal Medicine

基　　金：国家自然科学基金面上项目(81771741);国家重点研发计划(2017YFC09071);辽宁省教育厅第四批辽宁特聘教授人才项目(2014-187)。

摘　　要：甲状腺功能亢进症(简称甲亢)作为一种临床常见的病理综合征,严重影响患者的生活质量与身心健康。为此,中华医学会内分泌分会等5个学会联合制定《中国甲状腺功能亢进和其他原因甲状腺毒症诊治指南》(以下简称指南),该指南结合国内外最新研究证据与临床实践经验编写而成,为甲状腺毒症诊治方案提供了最新的指导建议。文章对指南的更新要点进行解读,并主要结合美国甲状腺学会发表的2016年《甲状腺功能亢进症和其他原因所致甲状腺毒症诊治指南》与之对比。Hyperthyroidism(hyperthyroidism),as a common clinical pathological syndrome,seriously affects patients'quality of life and physical and mental health.For this reason,five societies,including the Endocrine Branch of the Chinese Medical Association,have jointly developed the Chinese Guidelines for the Diagnosis and Treatment of Hyperthyroidism and Thyrotoxicosis of Other Causes,which combines the latest domestic and international research evidence with clinical practice and provides the most up-to-date guidance for the diagnosis and treatment of thyrotoxicosis.This article explains the updated points of the Guidelines and compares them with the 2016 Guidelines for the Management of Hyperthyroidism and Thyrotoxicosis of Other Causes published by the American Thyroid Association.

关 键 词：甲状腺功能亢进 甲状腺毒症 GRAVES眼病 甲状腺危象 药源性甲亢 

分 类 号：R581[医药卫生—内分泌]